04/17/2018
SeraCare Partners with NAVICAN on Implementation of Best-In-Class QC Workflow for TheraMap Precision Cancer Care™ Services
Leading NGS QC Software is integrated into their Philips IntelliSpace Genomics Platform
Press Releases
04/16/2018
SeraCare Announces Expansion of Industry’s Most Complete and Patient-Like ctDNA Reference Materials
Comprehensive circulating tumor DNA reference materials for NGS assay development, validation, and daily run controls
02/13/2018
SeraCare Announces Industry’s First CNV-Specific Reference Material for Gene Amplifications in Breast, Lung, and Brain Cancer
Truth-set NGS reference materials that broaden capabilities for tumor profiling assay validation and QC
01/08/2018
SeraCare Life Sciences Announces Joe Bernardo as New Company Chairman
SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, today announced that Joe Bernardo has joined SeraCare’s board of directors in the role of Chairman
11/08/2017
SeraCare Announces Industry's First Comprehensive NGS Reference Material for Hematologic Malignancies
Truth-set NGS reference materials to significantly advance validation and QC of myeloid assays
08/01/2017
SeraCare Announces the Launch of a Suite of Zika Virus Reference Materials for Improved Diagnostic Testing
Comprehensive suite of Zika IgM and recombinant Zika virus reference materials for method validation and evaluation of serological and molecular infectious disease assays.
07/18/2017
SeraCare Life Sciences Announces the Most Patient-Like cfDNA QC Technology
Truth set ctDNA materials to significantly advance the development and validation of liquid biopsy assays
06/27/2017
SeraCare announces QC software enhancements for higher confidence in NGS assay performance
iQ NGS QC Management software provides clinical NGS labs the tools and analytics necessary to easily assess, maintain, and demonstrate assay performance
03/23/2017
SeraCare Life Sciences announces launch of industry’s first multiplexed Inherited Cancer reference material
Expert-designed material for simplified validation of NGS-based panels
02/21/2017
SeraCare Life Sciences Announces New Highly Multiplexed Fusion RNA Assay Reference Standards
With Purified and FFPE formats, these standards are compatible with leading NGS-based Fusion RNA panels
02/14/2017
SeraCare Announces ‘Catalyzing Implementation of NGS-Based Tests’: A Four-Part Webinar Series
In partnership with GenomeWeb, these live presentations bring together clinical genomics industry key opinion leaders to discuss practical examples and best practices
02/08/2017
SeraCare Life Sciences Announces Presentation on Enabling Clinical Genomics with Highly Multiplexed Reference Materials
In partnership with Xtalks, this live webinar highlights a clinical laboratory case study
11/11/2016
SeraCare Launches Two New Seraseq™ Reference Materials for Clinical Oncology Assays
7-plex FFPE KRAS and updated RUO-GMP version of 40-plex Tumor Mutation DNA Mix now available
11/10/2016
SeraCare Life Sciences to Support Non-Invasive Prenatal Testing (NIPT) Proficiency Program in Collaboration with UK NEQAS
Seraseq™ Aneuploidy Reference Materials to be used in one of the first widespread NIPT external quality assessment (EQA) programs
11/09/2016
SeraCare Life Sciences collaborates with ArcherDX on RNA Fusion Reference Standards
Firms will collaborate to support Archer® FusionPlex® NGS-assay customers
10/19/2016
SeraCare Life Sciences Develops Industry’s First Multiplexed Cardiomyopathy Reference Material
SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, is announcing the launch of the industry’s first multiplexed reference material for inherited disease testing by next-generation sequencing (NGS) at the 2016 ASHG Annual Meeting in Vancouver.
10/12/2016
SeraCare Life Sciences Announces Preimplantation Genetic Screening (PGS) Reference Materials Partnership
SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, today announced it is partnering with AAB Proficiency Testing Service (AAB) for the development and use of preimplantation genetic screening (PGS) reference materials.
09/22/2016
France-Based Laboratoire CERBA Adopts Seraseq™ Aneuploidy Reference Materials for Non-Invasive Prenatal Testing (NIPT)
SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, has signed an agreement with Laboratoire CERBA, a leading European reference laboratory specializing in clinical pathology, to provide custom Seraseq™ Aneuploidy Reference Materials for use with Laboratoire CERBA's non-invasive prenatal testing (NIPT) assay.
08/03/2016
SeraCare Life Sciences Debuts its New Website at AACC
SeraCare Life Sciences, a leading partner to clinical laboratories and global in vitro diagnostics manufacturers, announced at the American Association of Clinical Chemistry (AACC) conference today the launch of its newly redesigned website, www.seracare.com.
07/26/2016
SeraCare Launches New QC Software for Clinical Laboratories Running Next-Generation Sequencing Assays
SeraCare Life Sciences, a leading partner to global in vitro diagnostics manufacturers and clinical laboratories, announced today that the company's precision medicine business unit has launched a groundbreaking new laboratory QC software specifically for clinical laboratories running next-generation sequencing (NGS)-based assays.